Description
What it is
Tirzepatide is a medicine that activates both the GIP and GLP-1 receptors, which are involved in appetite and blood sugar signaling. It is studied for its role in appetite regulation and blood sugar control. This is a compounded medication and is not FDA-approved. A provider decides if it is right for you.
About this option
This is a 1-month supply. A licensed provider reviews your medical history and questionnaire answers to decide whether treatment may be appropriate. If approved, the medication is prescribed and sent to you. Treatment is not guaranteed and is subject to provider discretion. Your provider selects the dose.
